A multitude of recent studies and success stories suggest artificial intelligence is on its way to topping doctors in accurately diagnosing diseases from asthma to breast cancer—seemingly a step in the right direction. But does the hype surrounding AI’s victories eclipse its shortcomings?
Artificial intelligence shows great promise in recognizing patterns, liberating physicians from keyboards and predicting outcomes, but where does it fall short? Medical guru Eric Topol does a deep dive into those topics and many more in his new book, Deep Medicine.
NVIDIA this week announced plans to buy chipmaker and its collaboration partner Mellanox Technologies for $6.9 billion. The move by the graphics chip giant seeks to help it push into the growing market for data center components by adding to chips that help speed the flow of information across servers.
Norman E. Sharpless, MD, director of the National Cancer Institute (NCI) since October 2017, has been announced as the new acting commissioner of the FDA. Sharpless replaces Scott Gottlieb, MD, who unexpectedly resigned from the position on March 5.
President Trump’s proposed “Budget for a Better America” for 2020 would cut Medicare spending by approximately $845 billion and Medicaid spending by approximately $241 billion over 10 years.
The FDA’s continued crackdown of the vaping and e-cigarette industry is questionable after the resignation of its commissioner Scott Gottlieb, who announced March 5 he would depart sometime in the next month.
A deep neural network crafted by research specialists at Dartmouth’s Norris Cotton Cancer Center identified different types of lung adenocarcinoma as well as practicing pathologists in a recent study, according to work published March 4 in Scientific Reports.
The Trump administration is reportedly considering requiring hospitals and other healthcare providers to publish the prices they charge insurance companies for services after the rates have been negotiated, The Wall Street Journal reported.
A 14-week health technology “sprint” sponsored by the U.S. Census Bureau and coordinated by HHS has produced an AI tool that developers claim could revolutionize the way researchers match cancer patients with clinical trials.
As electronic health records (EHRs) continue to play a huge role for healthcare operators, chief information officers have new concerns and priorities to ensure success. With rising cyberattacks on protected medical information about patients, CIOs are putting more importance on cybersecurity.
